Abstract | BACKGROUND: METHODS: RESULTS: CONCLUSIONS: Scanning with radiolabeled VIP can visualize intestinal tumors and metastases that express receptors for VIP.
|
Authors | I Virgolini, M Raderer, A Kurtaran, P Angelberger, S Banyai, Q Yang, S Li, M Banyai, J Pidlich, B Niederle, W Scheithauer, P Valent |
Journal | The New England journal of medicine
(N Engl J Med)
Vol. 331
Issue 17
Pg. 1116-21
(Oct 27 1994)
ISSN: 0028-4793 [Print] United States |
PMID | 7935635
(Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Iodine Radioisotopes
- Receptors, Somatostatin
- Receptors, Vasoactive Intestinal Peptide
- Vasoactive Intestinal Peptide
- Octreotide
|
Topics |
- Adenocarcinoma
(diagnostic imaging, metabolism)
- Carcinoid Tumor
(diagnostic imaging, metabolism)
- Colorectal Neoplasms
(diagnostic imaging, metabolism)
- Female
- Gastrointestinal Neoplasms
(diagnostic imaging, metabolism)
- Humans
- Insulinoma
(diagnostic imaging, metabolism)
- Iodine Radioisotopes
- Male
- Octreotide
- Pancreatic Neoplasms
(diagnostic imaging, metabolism)
- Radionuclide Imaging
- Receptors, Somatostatin
(analysis)
- Receptors, Vasoactive Intestinal Peptide
(analysis)
- Stomach Neoplasms
(diagnostic imaging, metabolism)
- Vasoactive Intestinal Peptide
|